Skip to main content

and
  1. No Access

    Article

    Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

    Elevated plasma levels of branched chain amino acids detected prior to pancreatic cancer diagnosis may result from whole body tissue breakdown occurring during the early stages of this disease.

    Jared R Mayers, Chen Wu, Clary B Clish, Peter Kraft, Margaret E Torrence in Nature Medicine (2014)

  2. Article

    Open Access

    Influence of dietary insulin scores on survival in colorectal cancer patients

    Although hyperinsulinemia is hypothesised to be involved in colorectal carcinogenesis, it remains unclear whether a diet inducing an elevated insulin response influences colorectal cancer (CRC) survival.

    Chen Yuan, Ying Bao, Kaori Sato, Katharina Nimptsch in British Journal of Cancer (2017)

  3. Article

    Open Access

    Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival

    Few studies have simultaneously assessed the prognostic value of the multiple classification systems for lymph node (LN) metastases in resected pancreatic ductal adenocarcinoma (PDAC).

    Vicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne in British Journal of Cancer (2017)

  4. Article

    Open Access

    Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk

    Individuals with a family history of cancer may be at increased risk of pancreatic cancer. Ashkenazi Jewish (AJ) individuals carry increased risk for pancreatic cancer and other cancer types.

    Tsuyoshi Hamada, Chen Yuan, Matthew B. Yurgelun in British Journal of Cancer (2019)

  5. No Access

    Article

    BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Programmed cell death 1 (PD-1) inhibitors have limited effect in pancreatic ductal adenocarcinoma (PDAC), underscoring the need to co-target alternative pathways. CXC chemokine receptor 4 (CXCR4) blockade prom...

    Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, Erkut Borazanci in Nature Medicine (2020)

  6. Article

    Open Access

    Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies

    Despite several plausible biological mechanisms linking proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) with colorectal tumorigenesis, their association with risk of colorectal cancer (CRC) h...

    Ana Babic, Xuehong Zhang, Vicente Morales-Oyarvide, Chen Yuan in British Journal of Cancer (2020)

  7. No Access

    Article

    The oral microbiome in relation to pancreatic cancer risk in African Americans

    African Americans have the highest pancreatic cancer incidence of any racial/ethnic group in the United States. The oral microbiome was associated with pancreatic cancer risk in a recent study, but no such stu...

    Jessica L. Petrick, Jeremy E. Wilkinson, Dominique S. Michaud in British Journal of Cancer (2022)

  8. No Access

    Article

    Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohorts

    Gallstones may result in inflammation, altered bile flow, and changes in metabolic hormone levels, thereby increasing cancer risk. However, previous studies for gallstones and cancers of the liver, biliary tra...

    **ao Luo, Wanshui Yang, Amit D. Joshi, Kana Wu in British Journal of Cancer (2022)

  9. Article

    Open Access

    A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories

    Pancreatic cancer is an aggressive disease that typically presents late with poor outcomes, indicating a pronounced need for early detection. In this study, we applied artificial intelligence methods to clinic...

    Davide Placido, Bo Yuan, Jessica X. Hjaltelin, Chunlei Zheng in Nature Medicine (2023)